Google Commits to EU AI Code Despite Concerns of Slowing Progress
Google will sign the EU’s AI code despite expressing concerns. The code offers legal clarity and reduced burdens for AI…
SASHA Empowers Users by Giving Control Back Over Digital Images
SASHA embeds invisible signatures into images, maintaining data integrity post-manipulation. The decentralized tool empowers users with image-sharing control and accountability.…
Maxi Mobility Secures €1.2M to Drive Electric Vehicle Adoption
Maxi Mobility raised €1.2M to ease electric vehicle transition. Funding aims to enhance tech and infrastructure in Milan and Rome.…
Retab Advances Document Automation with New Funding and Platform Launch
Retab launches with $3.5M funding, enhancing document automation. The platform offers reliable, developer-friendly document data extraction. Retab aims to be…
Greek Startup Delian Alliance Industries Raises $14M to Expand Autonomous Weapons Development
Delian Alliance Industries raised $14 million in Series A funding. The company focuses on autonomous weapons using AI and commercial…
Aiphoria Secures $34M Investment to Expand AI Ventures in US and Europe
Aiphoria raises $34M to expand in the US and Europe. The funding highlights its approach to scalable AI integration. Investment…
Microsoft Negotiates to Sustain Ties with OpenAI Amid AGI Developments
Microsoft and OpenAI are revising terms for sustained technology access. Negotiations focus on barriers due to OpenAI's AGI development. This…
Crypto Derivatives Firm D2X Secures €4.3M to Expand Trading Operations
D2X, an Amsterdam-based crypto derivatives firm, raised €4.3M in funding. Significant investors include CMT Digital and Circle Ventures supporting the…
Centauri Strengthens Fight Against Drug-Resistant Infections with CARB-X Funding Boost
Centauri Therapeutics secures $5.1 million from CARB-X, totaling $12.3 million. Focus is on developing a broad-spectrum antimicrobial from their ABX-01…
Psylink Advances Biotech Platform with New Funding
Psylink raises €501,521 to expand its biotechnology and fungal compound therapies. The firm's dual R&D focuses on yeast biosynthesis and…
